JAC Advance Access published online on April 14, 2003
Journal of Antimicrobial Chemotherapy, doi:10.1093/jac/dkg218
© 2003 by The British Society for Antimicrobial Chemotherapy
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Brief report
1 Department of Medical
Microbiology, University Medical Center Nijmegen, PO Box 9101, 6500
HB Nijmegen; Nijmegen University
Center for Infectious Diseases; Centraalbureau
voor Schimmelcultures, Utrecht
* Corresponding author. E-mail: p.verweij{at}mmb.umcn.nl.
Received 17 December 2002
; revised 25 January 2003
; accepted 16 February 2003
The combined effects of antifungal and antibiotic drugs
against Exophiala spinifera were evaluated in
vitro by the chequer-board method, calculated as a fractional
inhibitory concentration (FIC) index. Amphotericin B was combined
with flucytosine and ciprofloxacin, whereas itraconazole was combined
with ciprofloxacin, levofloxacin, lomefloxacin and sulfadiazine.
Synergic effects were observed for the combinations of itraconazole
with ciprofloxacin and levofloxacin, and amphotericin B with ciprofloxacin
and flucytosine. No antagonism was observed for any combination
tested.
Keywords: Exophiala, black yeasts, quinolones,
drug combinations
In vitro activity of amphotericin
B and itraconazole in combination with flucytosine, sulfadiazine
and quinolones against
Exophiala spinifera
2 Department of Medical
Microbiology, University Medical Center Nijmegen, PO Box 9101, 6500
HB Nijmegen; Nijmegen University
Center for Infectious Diseases
3 Centraalbureau
voor Schimmelcultures, Utrecht; Institute for Biodiversity and
Ecosystem Dynamics, University of Amsterdam, Amsterdam, The Netherlands
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
M. Cuenca-Estrella Combinations of antifungal agents in therapy-what value are they? J. Antimicrob. Chemother., November 1, 2004; 54(5): 854 - 869. [Abstract] [Full Text] [PDF] |
||||
